Skip to main content

NS Wind Down Co., Inc.

NSTGDelisted Apr 9, 2024
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001401708

NS Wind Down Co., Inc. was delisted on Apr 9, 2024; its insiders filed their last Form 4 on May 8, 2024; 88 institutions reported holding it in 13F filings for Q4 2023, worth $28.3M in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by NS Wind Down Co., Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for NS Wind Down Co., Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for NS Wind Down Co., Inc.
NameTitleLast reported holdingLast filingFilings, past year
Waite Charles P JrDirector79,284May 8, 20240
Finney Elisha WDirector62,579May 8, 20240
Young WilliamDirector102,684May 8, 20240
Malloy KirkDirector65,384May 8, 20240
Norden GregoryDirector88,552May 8, 20240
Bailey K ThomasChief Financial Officer304,163May 8, 20240
Gray R BradleyPresident and CEO1,108,477May 8, 20240
Beechem Joseph MSVP, Research & Development288,943May 8, 20240
Rollison Dana E.Director62,077May 8, 20240
George JanetDirector62,077May 8, 20240
Foy Teresa M.Director55,091May 8, 20240
Garland Jonathan ToddChief Commercial Officer200,000May 8, 20240
Gerace John D.Chief Commercial Officer14,780Mar 7, 20230
Kania Don RDirector9,410Jun 17, 20220
Hershberg RobertDirector10,716Apr 18, 20220
Brown J. ChadSVP, Sales & Marketing162Jan 31, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 30, 2023 (view filing)May 255 daysGray R BradleyPresident and CEOPPurchase+30.0K$5.80+$174.0K+9.7%338.4K after
May 30, 2023 (view filing)May 264 daysBailey K ThomasChief Financial OfficerPPurchase+15.0K$5.76+$86.4K+24.8%75.4K after
May 26, 2023 (view filing)May 242 daysYoung WilliamDirectorPPurchase+35.4K$5.69+$201.4K+313.3%46.7K after
Mar 14, 2023 (view filing)Mar 131 dayWaite Charles P JrDirectorPPurchase+12.0K$8.35+$100.2K+106.2%23.3K after
Mar 8, 2023 (view filing)Mar 71 dayNorden GregoryDirectorPPurchase+12.5K$9.84+$123.0K+110.6%23.8K after
Dec 14, 2022 (view filing)Dec 131 dayBailey K ThomasChief Financial OfficerPPurchase+29.2K$8.05+$234.7K+150.5%48.5K after
Dec 14, 2022 (view filing)Dec 12-132 daysGray R BradleyPresident and CEOPPurchase+67.7K$7.38+$499.4K+33.4%270.0K after2 lots
Jun 21, 2022 (view filing)Jun 174 daysFinney Elisha WDirectorSSale−1.95K$12.41−$24.1K−22.8%6.59K after
Mar 16, 2022 (view filing)Mar 151 dayGray R BradleyPresident and CEOSSale−8.63K$27.81−$239.9K−4.1%202.3K after
Mar 16, 2022 (view filing)Mar 151 dayBeechem Joseph MSVP, Research & DevelopmentSSale−2.44K$27.81−$67.7K−2.8%85.4K after
Mar 16, 2022 (view filing)Mar 151 dayBailey K ThomasChief Financial OfficerSSale−2.11K$27.81−$58.7K−9.8%19.4K after
Mar 11, 2022 (view filing)Mar 101 dayBailey K ThomasChief Financial OfficerSSale−5.00K$33.81−$169.1K−23.7%16.1K after
Mar 9, 2022 (view filing)Mar 81 dayGray R BradleyPresident and CEOSSale−9.67K$33.06−$319.6K−4.9%188.9K after
Mar 9, 2022 (view filing)Mar 81 dayBeechem Joseph MSVP, Research & DevelopmentSSale−2.97K$33.06−$98.1K−3.5%82.4K after
Mar 9, 2022 (view filing)Mar 81 dayBailey K ThomasChief Financial OfficerSSale−3.06K$33.06−$101.1K−12.7%21.1K after
Feb 28, 2022 (view filing)Feb 244 daysYoung WilliamDirectorSSale−20.3K$32.20−$655.0K−73.3%7.41K after6 lots
Nov 19, 2021 (view filing)Nov 172 daysBailey K ThomasChief Financial OfficerSSale−7.84K$46.74−$366.6K−100.0%0 after2 lots
Nov 12, 2021 (view filing)Nov 102 daysGray R BradleyPresident and CEOSSale−25.0K$46.29−$1.16M−16.9%123.3K after6 lots
Oct 21, 2021 (view filing)Aug 1666 daysMalloy KirkDirectorSSale−2.50K$55.82−$139.6K−31.2%5.51K afterAmended
Sep 15, 2021 (view filing)Sep 132 daysMalloy KirkDirectorSSale−3.00K$59.37−$178.1K−31.5%6.51K afterFrom original
Sep 10, 2021 (view filing)Sep 82 daysGray R BradleyPresident and CEOSSale−33.3K$57.92−$1.93M−19.7%135.8K after3 lots
Sep 3, 2021 (view filing)Sep 21 dayBeechem Joseph MSVP, Research & DevelopmentSSale−23.1K$61.14−$1.41M−25.3%68.3K after2 lots
Aug 19, 2021 (view filing)Aug 172 daysBailey K ThomasChief Financial OfficerSSale−7.84K$51.98−$407.8K−100.0%0 after2 lots
Aug 3, 2021 (view filing)Jul 304 daysBrown J. ChadSVP, Sales & MarketingSSale−11.1K$62.09−$689.6K−100.0%0 after2 lots
Jul 15, 2021 (view filing)Jul 132 daysMalloy KirkDirectorSSale−1.50K$61.16−$91.7K−18.7%6.51K after